Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Angiotensin-converting enzyme |
Is a |
False |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Thyroglobulin protease |
Is a |
False |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Trypsinogen activation peptide |
Is a |
False |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Mast cell tryptase |
Is a |
False |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Serine protease |
Is a |
False |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Elastase |
Is a |
False |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Cathepsin |
Is a |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pepsin A (substance) |
Is a |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Papain |
Is a |
False |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Subtilisin |
Is a |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Trypsin |
Is a |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bromelin |
Is a |
False |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pancreatic elastase (substance) |
Is a |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Bromelains (substance) |
Is a |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Factor I |
Is a |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 66400unt/20000unt/75000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 3000unt/2400unt/3000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 65000unt/20000unt/65000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase, pancreatic + protease, pancreatic 12500unt/1000unt/12500unt tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 8000unt/30000unt/30000unt tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Protease-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 20000unt/4500unt/25000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 30000unt/8000unt/30000unt tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 16600unt/5000unt/18750unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 30000unt/8000unt/30000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 30000unt/10000unt/30000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase, pancreatic + protease, pancreatic 65000unt/20000unt/65000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 40000unt/8000unt/45000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 33200unt/10000unt/37500unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 12000unt/4000unt/12000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 39000unt/12000unt/39000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing amylase and substance with protease mechanism of action and triacylglycerol lipase |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 6000unt/16000unt/6000unt tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 664400unt/20000unt/75000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 70000unt/16800unt/70000unt powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 56000unt/20000unt/44000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 58500unt/18000unt/58500unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 20000unt/5000unt/20000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 25000unt/4000unt/25000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase + lipase + protease 48000unt/16000unt/48000unt capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing human protease inhibitor protein (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Promelase |
Is a |
False |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Trypsin + trypsinogen |
Is a |
False |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Matrix metallopeptidase 2 |
Is a |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Matrix metallopeptidase 9 |
Is a |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Free pancreatic elastase |
Is a |
False |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Amylase 25000 unit and endopeptidase 25000 unit and triacylglycerol lipase 4000 unit oral capsule |
Has basis of strength substance (attribute) |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amylase 25000 unit and endopeptidase 25000 unit and triacylglycerol lipase 4000 unit oral capsule |
Has precise active ingredient |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 10000 unit gastro-resistant oral capsule |
Has basis of strength substance (attribute) |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 10000 unit gastro-resistant oral capsule |
Has precise active ingredient |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amylase 56000 unit and endopeptidase 44000 unit and triacylglycerol lipase 20000 unit oral capsule |
Has precise active ingredient |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amylase 56000 unit and endopeptidase 44000 unit and triacylglycerol lipase 20000 unit oral capsule |
Has basis of strength substance (attribute) |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amylase 39000 unit and endopeptidase 39000 unit and triacylglycerol lipase 12000 unit/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amylase 39000 unit and endopeptidase 39000 unit and triacylglycerol lipase 12000 unit/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amylase 40000 unit and endopeptidase 45000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amylase 40000 unit and endopeptidase 45000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amylase and endopeptidase and triacylglycerol lipase only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only amylase and endopeptidase and triacylglycerol lipase in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amylase- and endopeptidase- and triacylglycerol lipase-containing product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amylase 16600 unit and endopeptidase 18800 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amylase 16600 unit and endopeptidase 18800 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing amylase and endopeptidase and pancreatic lipase (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amylase 12500 unit and endopeptidase 12500 unit and triacylglycerol lipase 1000 unit/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amylase 12500 unit and endopeptidase 12500 unit and triacylglycerol lipase 1000 unit/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit oral capsule |
Has basis of strength substance (attribute) |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit oral capsule |
Has precise active ingredient |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing amylase and endopeptidase and pancreatic lipase in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing amylase and endopeptidase and triacylglycerol lipase in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amylase and endopeptidase and pancreatic lipase only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amylase 58500 unit and endopeptidase 58500 unit and triacylglycerol lipase 18000 unit/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amylase 58500 unit and endopeptidase 58500 unit and triacylglycerol lipase 18000 unit/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amylase 6000 unit and endopeptidase 6000 unit and triacylglycerol lipase 16000 unit/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amylase 20000 unit and endopeptidase 25000 unit and pancreatic lipase 4500 unit/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amylase 12000 unit and endopeptidase 12000 unit and triacylglycerol lipase 4000 unit/1 each gastro-resistant oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amylase 12000 unit and endopeptidase 12000 unit and triacylglycerol lipase 4000 unit/1 each gastro-resistant oral capsule (clinical drug) |
Has precise active ingredient |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral tablet (clinical drug) |
Has basis of strength substance (attribute) |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amylase 30000 unit and endopeptidase 30000 unit and triacylglycerol lipase 8000 unit/1 each conventional release oral tablet (clinical drug) |
Has precise active ingredient |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amylase 33200 unit and endopeptidase 37500 unit and triacylglycerol lipase 10000 unit/1 each gastro-resistant oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amylase 33200 unit and endopeptidase 37500 unit and triacylglycerol lipase 10000 unit/1 each gastro-resistant oral capsule (clinical drug) |
Has precise active ingredient |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amylase 65000 unit and endopeptidase 65000 unit and triacylglycerol lipase 20000 unit oral capsule |
Has basis of strength substance (attribute) |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amylase 65000 unit and endopeptidase 65000 unit and triacylglycerol lipase 20000 unit oral capsule |
Has precise active ingredient |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amylase 66400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit gastro-resistant oral capsule |
Has basis of strength substance (attribute) |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amylase 66400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit gastro-resistant oral capsule |
Has precise active ingredient |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amylase 20000 unit and endopeptidase 20000 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug) |
Has basis of strength substance (attribute) |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing precisely amylase 20000 unit and endopeptidase 20000 unit and triacylglycerol lipase 5000 unit/1 each conventional release oral capsule (clinical drug) |
Has precise active ingredient |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amylase 3000 unit and endopeptidase 3000 unit and triacylglycerol lipase 2400 unit oral capsule |
Has basis of strength substance (attribute) |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amylase 3000 unit and endopeptidase 3000 unit and triacylglycerol lipase 2400 unit oral capsule |
Has precise active ingredient |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amylase 48000 unit and endopeptidase 48000 unit and triacylglycerol lipase 16000 unit gastro-resistant oral capsule |
Has basis of strength substance (attribute) |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amylase 48000 unit and endopeptidase 48000 unit and triacylglycerol lipase 16000 unit gastro-resistant oral capsule |
Has precise active ingredient |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amylase 664400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit gastro-resistant oral capsule |
Has basis of strength substance (attribute) |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amylase 664400 unit and endopeptidase 75000 unit and triacylglycerol lipase 20000 unit gastro-resistant oral capsule |
Has precise active ingredient |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Amylase and endopeptidase and pancreatic lipase only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Chymotrypsin |
Is a |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pepsin B |
Is a |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pepsin C |
Is a |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Chymotrypsin C |
Is a |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oryzin (substance) |
Is a |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Pancreatic elastase II |
Is a |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Polymorphonuclear neutrophil elastase |
Is a |
True |
Endopeptidase |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|